Additionally, blood samples were obtained from patientswith stable CAD, demonstrating that higher GDF-15 plasma concentrations atbaseline were associated with an increased event rate of the primary compositeend point (death from CVD, nonfatal myocardial infarction, or nonfatal stroke)[37]. This evidence concerns the gene GDF15 and stroke disorder.